{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:13:26Z","timestamp":1767921206497,"version":"3.49.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203233, 32400991"],"award-info":[{"award-number":["82203233, 32400991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16026-0","type":"journal-article","created":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T04:51:21Z","timestamp":1755406281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunological role and prognostic value of ITGA3 and ITGA5 in oral squamous cell carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Lujuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,17]]},"reference":[{"key":"16026_CR1","doi-asserted-by":"publisher","first-page":"105451","DOI":"10.1016\/j.oraloncology.2021.105451","volume":"121","author":"A Chamoli","year":"2021","unstructured":"Chamoli, A. et al. Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics. Oral Oncol. 121, 105451. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105451 (2021).","journal-title":"Oral Oncol."},{"key":"16026_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41392-022-00939-7","volume":"7","author":"T Fan","year":"2022","unstructured":"Fan, T. et al. NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy. Signal. Transduct. Target. Ther. 7, 130. https:\/\/doi.org\/10.1038\/s41392-022-00939-7 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"16026_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41368-020-0084-8","volume":"12","author":"Z Mei","year":"2020","unstructured":"Mei, Z., Huang, J., Qiao, B. & Lam, A. K. Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma. Int. J. Oral Sci. 12, 16. https:\/\/doi.org\/10.1038\/s41368-020-0084-8 (2020).","journal-title":"Int. J. Oral Sci."},{"key":"16026_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers. 6, 92. https:\/\/doi.org\/10.1038\/s41572-020-00224-3 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"16026_CR5","doi-asserted-by":"publisher","unstructured":"Katirachi, S. K., Gronlund, M. P., Jakobsen, K. K., Gronhoj, C. & von Buchwald, C. The prevalence of HPV in oral cavity squamous cell carcinoma. Viruses 15 https:\/\/doi.org\/10.3390\/v15020451 (2023).","DOI":"10.3390\/v15020451"},{"key":"16026_CR6","doi-asserted-by":"publisher","first-page":"155489","DOI":"10.1016\/j.prp.2024.155489","volume":"261","author":"D Jagadeesan","year":"2024","unstructured":"Jagadeesan, D. et al. Comprehensive insights into oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances. Pathol. Res. Pract. 261, 155489. https:\/\/doi.org\/10.1016\/j.prp.2024.155489 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"16026_CR7","doi-asserted-by":"publisher","unstructured":"Kitamura, N. et al. Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22010240 (2020).","DOI":"10.3390\/ijms22010240"},{"key":"16026_CR8","doi-asserted-by":"publisher","unstructured":"Pekarek, L. et al. Emerging histological and serological biomarkers in oral squamous cell carcinoma: applications in diagnosis, prognosis evaluation and personalized therapeutics (Review). Oncol. Rep. 50 https:\/\/doi.org\/10.3892\/or.2023.8650 (2023).","DOI":"10.3892\/or.2023.8650"},{"key":"16026_CR9","doi-asserted-by":"publisher","first-page":"1269211","DOI":"10.3389\/fonc.2024.1269211","volume":"14","author":"A Chauhan","year":"2024","unstructured":"Chauhan, A. et al. A FACS-based novel isolation technique identifies heterogeneous CTCs in oral squamous cell carcinoma. Front. Oncol. 14, 1269211. https:\/\/doi.org\/10.3389\/fonc.2024.1269211 (2024).","journal-title":"Front. Oncol."},{"key":"16026_CR10","doi-asserted-by":"publisher","unstructured":"Payne, K. et al. Immediate sample fixation increases Circulating tumour cell (CTC) capture and preserves phenotype in head and neck squamous cell carcinoma: towards a standardised approach to microfluidic CTC biomarker discovery. Cancers (Basel). 13. https:\/\/doi.org\/10.3390\/cancers13215519 (2021).","DOI":"10.3390\/cancers13215519"},{"key":"16026_CR11","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.3390\/curroncol30040283","volume":"30","author":"M Badwelan","year":"2023","unstructured":"Badwelan, M., Muaddi, H., Ahmed, A., Lee, K. T. & Tran, S. D. Oral squamous cell carcinoma and concomitant primary tumors, what do we know? A review of the literature. Curr. Oncol. 30, 3721\u20133734. https:\/\/doi.org\/10.3390\/curroncol30040283 (2023).","journal-title":"Curr. Oncol."},{"key":"16026_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s40425-019-0662-5","volume":"7","author":"EEW Cohen","year":"2019","unstructured":"Cohen, E. E. W. et al. The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J. Immunother Cancer. 7, 184. https:\/\/doi.org\/10.1186\/s40425-019-0662-5 (2019).","journal-title":"J. Immunother Cancer"},{"key":"16026_CR13","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1038\/s41467-021-26472-9","volume":"12","author":"JL Vos","year":"2021","unstructured":"Vos, J. L. et al. Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma. Nat. Commun. 12, 7348. https:\/\/doi.org\/10.1038\/s41467-021-26472-9 (2021).","journal-title":"Nat. Commun."},{"key":"16026_CR14","doi-asserted-by":"publisher","first-page":"e926800","DOI":"10.12659\/MSM.926800","volume":"26","author":"C Feng","year":"2020","unstructured":"Feng, C. et al. Expression and prognostic analyses of ITGA3, ITGA5, and ITGA6 in head and neck squamous cell carcinoma. Med. Sci. Monit. 26, e926800. https:\/\/doi.org\/10.12659\/MSM.926800 (2020).","journal-title":"Med. Sci. Monit."},{"key":"16026_CR15","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/jcb.27681","volume":"120","author":"M Najafi","year":"2019","unstructured":"Najafi, M., Farhood, B. & Mortezaee, K. Extracellular matrix (ECM) stiffness and degradation as cancer drivers. J. Cell. Biochem. 120, 2782\u20132790. https:\/\/doi.org\/10.1002\/jcb.27681 (2019).","journal-title":"J. Cell. Biochem."},{"key":"16026_CR16","doi-asserted-by":"publisher","first-page":"120667","DOI":"10.1016\/j.biomaterials.2021.120667","volume":"269","author":"CE Witherel","year":"2021","unstructured":"Witherel, C. E. et al. Regulation of extracellular matrix assembly and structure by hybrid M1\/M2 macrophages. Biomaterials 269, 120667. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120667 (2021).","journal-title":"Biomaterials"},{"key":"16026_CR17","doi-asserted-by":"publisher","first-page":"658547","DOI":"10.3389\/fonc.2021.658547","volume":"11","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. ITGA3 is associated with immune cell infiltration and serves as a favorable prognostic biomarker for breast cancer. Front. Oncol. 11, 658547. https:\/\/doi.org\/10.3389\/fonc.2021.658547 (2021).","journal-title":"Front. Oncol."},{"key":"16026_CR18","doi-asserted-by":"publisher","first-page":"844144","DOI":"10.3389\/fonc.2022.844144","volume":"12","author":"S Li","year":"2022","unstructured":"Li, S. et al. ITGA5 is a novel oncogenic biomarker and correlates with tumor immune microenvironment in gliomas. Front. Oncol. 12, 844144. https:\/\/doi.org\/10.3389\/fonc.2022.844144 (2022).","journal-title":"Front. Oncol."},{"key":"16026_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41419-024-06843-y","volume":"15","author":"H Lu","year":"2024","unstructured":"Lu, H. et al. IGFBP2\/ITGA5 promotes gefitinib resistance via activating STAT3\/CXCL1 axis in non-small cell lung cancer. Cell. Death Dis. 15, 447. https:\/\/doi.org\/10.1038\/s41419-024-06843-y (2024).","journal-title":"Cell. Death Dis."},{"key":"16026_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12885-021-07996-1","volume":"21","author":"H Zhu","year":"2021","unstructured":"Zhu, H., Wang, G., Zhu, H. & Xu, A. ITGA5 is a prognostic biomarker and correlated with immune infiltration in Gastrointestinal tumors. BMC Cancer. 21, 269. https:\/\/doi.org\/10.1186\/s12885-021-07996-1 (2021).","journal-title":"BMC Cancer"},{"key":"16026_CR21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"16026_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"16026_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan, Y. et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int. J. Oral Sci. 15, 44. https:\/\/doi.org\/10.1038\/s41368-023-00249-w (2023).","journal-title":"Int. J. Oral Sci."},{"key":"16026_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.oraloncology.2013.06.002","volume":"49","author":"C Fakhry","year":"2013","unstructured":"Fakhry, C. & D\u2019Souza, G. Discussing the diagnosis of HPV-OSCC: common questions and answers. Oral Oncol. 49, 863\u2013871. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.06.002 (2013).","journal-title":"Oral Oncol."},{"key":"16026_CR25","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/odi.13814","volume":"28","author":"MAP de Lima","year":"2022","unstructured":"de Lima, M. A. P. et al. Evaluation of HPV and EBV in OSCC and the expression of p53, p16, E-cadherin, COX-2, MYC, and MLH1. Oral Dis. 28, 1104\u20131122. https:\/\/doi.org\/10.1111\/odi.13814 (2022).","journal-title":"Oral Dis."},{"key":"16026_CR26","doi-asserted-by":"publisher","first-page":"110873","DOI":"10.1016\/j.biopha.2020.110873","volume":"132","author":"B Lin","year":"2020","unstructured":"Lin, B. et al. Tumor-infiltrating lymphocytes: warriors fight against tumors powerfully. Biomed. Pharmacother. 132, 110873. https:\/\/doi.org\/10.1016\/j.biopha.2020.110873 (2020).","journal-title":"Biomed. Pharmacother"},{"key":"16026_CR27","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","volume":"18","author":"ST Paijens","year":"2021","unstructured":"Paijens, S. T., Vledder, A., de Bruyn, M. & Nijman, H. W. Tumor-infiltrating lymphocytes in the immunotherapy era. Cell. Mol. Immunol. 18, 842\u2013859. https:\/\/doi.org\/10.1038\/s41423-020-00565-9 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"16026_CR28","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.ccell.2024.06.015","volume":"42","author":"AA Sarnaik","year":"2024","unstructured":"Sarnaik, A. A., Hwu, P., Mule, J. J. & Pilon-Thomas, S. Tumor-infiltrating lymphocytes: A new hope. Cancer Cell. 42, 1315\u20131318. https:\/\/doi.org\/10.1016\/j.ccell.2024.06.015 (2024).","journal-title":"Cancer Cell."},{"key":"16026_CR29","doi-asserted-by":"publisher","first-page":"105348","DOI":"10.1016\/j.oraloncology.2021.105348","volume":"119","author":"Y Peng","year":"2021","unstructured":"Peng, Y. et al. Single-cell profiling of tumor-infiltrating TCF1\/TCF7(+) T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures\/organs and a superior prognosis in oral cancer. Oral Oncol. 119, 105348. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105348 (2021).","journal-title":"Oral Oncol."},{"key":"16026_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s11658-019-0162-0","volume":"24","author":"Y Bao","year":"2019","unstructured":"Bao, Y. et al. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that May be associated with breast cancer. Cell. Mol. Biol. Lett. 24, 38. https:\/\/doi.org\/10.1186\/s11658-019-0162-0 (2019).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"16026_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.ymthe.2021.08.011","volume":"30","author":"X Lin","year":"2022","unstructured":"Lin, X. et al. LncRNA ITGB8-AS1 functions as a CeRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling. Mol. Ther. 30, 688\u2013702. https:\/\/doi.org\/10.1016\/j.ymthe.2021.08.011 (2022).","journal-title":"Mol. Ther."},{"key":"16026_CR32","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1177\/00220345241262759","volume":"103","author":"XX Wang","year":"2024","unstructured":"Wang, X. X. et al. Salivary Microbiome relates to neoadjuvant immunotherapy response in OSCC. J. Dent. Res. 103, 988\u2013998. https:\/\/doi.org\/10.1177\/00220345241262759 (2024).","journal-title":"J. Dent. Res."},{"key":"16026_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao, W., Wang, X., Zhou, Y., Wang, X. & Yu, Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal. Transduct. Target. Ther. 7, 196. https:\/\/doi.org\/10.1038\/s41392-022-01046-3 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"16026_CR34","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei, G., Zhuang, L. & Gan, B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 42, 513\u2013534. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.011 (2024).","journal-title":"Cancer Cell."},{"key":"16026_CR35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.molmed.2021.06.014","volume":"27","author":"H Xu","year":"2021","unstructured":"Xu, H., Ye, D., Ren, M., Zhang, H. & Bi, F. Ferroptosis in the tumor microenvironment: perspectives for immunotherapy. Trends Mol. Med. 27, 856\u2013867. https:\/\/doi.org\/10.1016\/j.molmed.2021.06.014 (2021).","journal-title":"Trends Mol. Med."},{"key":"16026_CR36","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/d41573-022-00146-7","volume":"21","author":"S Crunkhorn","year":"2022","unstructured":"Crunkhorn, S. Targeting drug-resistant glioblastoma. Nat. Rev. Drug Discov. 21, 711. https:\/\/doi.org\/10.1038\/d41573-022-00146-7 (2022).","journal-title":"Nat. Rev. Drug Discov"},{"key":"16026_CR37","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1158\/0008-5472.CAN-21-3844","volume":"82","author":"PK Dhanyamraju","year":"2022","unstructured":"Dhanyamraju, P. K., Schell, T. D., Amin, S. & Robertson, G. P. Drug-Tolerant persister cells in cancer therapy resistance. Cancer Res. 82, 2503\u20132514. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-3844 (2022).","journal-title":"Cancer Res."},{"key":"16026_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan, N., Baselga, J. & Hyman, D. M. A view on drug resistance in cancer. Nature 575, 299\u2013309. https:\/\/doi.org\/10.1038\/s41586-019-1730-1 (2019).","journal-title":"Nature"},{"key":"16026_CR39","doi-asserted-by":"publisher","first-page":"104799","DOI":"10.1016\/j.oraloncology.2020.104799","volume":"107","author":"A Almangush","year":"2020","unstructured":"Almangush, A. et al. Staging and grading of oral squamous cell carcinoma: an update. Oral Oncol. 107, 104799. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104799 (2020).","journal-title":"Oral Oncol."},{"key":"16026_CR40","doi-asserted-by":"publisher","first-page":"591088","DOI":"10.3389\/fimmu.2020.591088","volume":"11","author":"M Irfan","year":"2020","unstructured":"Irfan, M., Delgado, R. Z. R. & Frias-Lopez, J. The oral Microbiome and cancer. Front. Immunol. 11, 591088. https:\/\/doi.org\/10.3389\/fimmu.2020.591088 (2020).","journal-title":"Front. Immunol."},{"key":"16026_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12032-023-01992-0","volume":"40","author":"PP Vatsa","year":"2023","unstructured":"Vatsa, P. P. et al. Role of epigenetics in OSCC: an Understanding above genetics. Med. Oncol. 40, 122. https:\/\/doi.org\/10.1007\/s12032-023-01992-0 (2023).","journal-title":"Med. Oncol."},{"key":"16026_CR42","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1111\/odi.14700","volume":"30","author":"Z Yang","year":"2024","unstructured":"Yang, Z., Zhang, S., Ji, N., Li, J. & Chen, Q. The evil companion of OSCC: Candida albicans. Oral Dis. 30, 1873\u20131886. https:\/\/doi.org\/10.1111\/odi.14700 (2024).","journal-title":"Oral Dis."},{"key":"16026_CR43","doi-asserted-by":"publisher","first-page":"994643","DOI":"10.3389\/fphar.2022.994643","volume":"13","author":"Q Gou","year":"2022","unstructured":"Gou, Q., Zheng, L. L. & Huang, H. Unravelling the roles of autophagy in OSCC: A renewed perspective from mechanisms to potential applications. Front. Pharmacol. 13, 994643. https:\/\/doi.org\/10.3389\/fphar.2022.994643 (2022).","journal-title":"Front. Pharmacol."},{"key":"16026_CR44","doi-asserted-by":"publisher","first-page":"1198269","DOI":"10.3389\/fimmu.2023.1198269","volume":"14","author":"PJ Saikia","year":"2023","unstructured":"Saikia, P. J., Pathak, L., Mitra, S. & Das, B. The emerging role of oral microbiota in oral cancer initiation, progression and stemness. Front. Immunol. 14, 1198269. https:\/\/doi.org\/10.3389\/fimmu.2023.1198269 (2023).","journal-title":"Front. Immunol."},{"key":"16026_CR45","doi-asserted-by":"publisher","first-page":"464","DOI":"10.6026\/97320630019464","volume":"19","author":"J Pazhani","year":"2023","unstructured":"Pazhani, J., Veeraraghavan, V. P. & Jayaraman, S. Molecular Docking analysis of Proflavin with the Wnt pathway targets for OSCC. Bioinformation 19, 464\u2013466. https:\/\/doi.org\/10.6026\/97320630019464 (2023).","journal-title":"Bioinformation"},{"key":"16026_CR46","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.7150\/ijms.94566","volume":"21","author":"P Rajendran","year":"2024","unstructured":"Rajendran, P. et al. PI3K\/AKT signaling pathway mediated autophagy in oral Carcinoma - A comprehensive review. Int. J. Med. Sci. 21, 1165\u20131175. https:\/\/doi.org\/10.7150\/ijms.94566 (2024).","journal-title":"Int. J. Med. Sci."},{"key":"16026_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41368-023-00221-8","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Down-regulation of DNA key protein-FEN1 inhibits OSCC growth by affecting immunosuppressive phenotypes via IFN-gamma\/JAK\/STAT-1. Int. J. Oral Sci. 15, 17. https:\/\/doi.org\/10.1038\/s41368-023-00221-8 (2023).","journal-title":"Int. J. Oral Sci."},{"key":"16026_CR48","doi-asserted-by":"publisher","unstructured":"Zhang, Z. et al. PER2 binding to HSP90 enhances immune response against oral squamous cell carcinoma by inhibiting IKK\/NF-kappaB pathway and PD-L1 expression. J. Immunother Cancer. 11 https:\/\/doi.org\/10.1136\/jitc-2023-007627 (2023).","DOI":"10.1136\/jitc-2023-007627"},{"key":"16026_CR49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329\u2013335. https:\/\/doi.org\/10.1038\/nature15756 (2015).","journal-title":"Nature"},{"key":"16026_CR50","doi-asserted-by":"publisher","unstructured":"Liu, M. et al. ZIP4 Increases expression of transcription factor ZEB1 to promote integrin alpha3beta1 signaling and inhibit expression of the gemcitabine transporter ENT1 in pancreatic cancer cells. Gastroenterology 158, 679\u2013692 e671 (2020). https:\/\/doi.org\/10.1053\/j.gastro.2019.10.038","DOI":"10.1053\/j.gastro.2019.10.038"},{"key":"16026_CR51","doi-asserted-by":"publisher","first-page":"27063","DOI":"10.1038\/s41598-024-75770-x","volume":"14","author":"W Tan","year":"2024","unstructured":"Tan, W. et al. Elevated ITGA3 expression serves as a novel prognostic biomarker and regulates tumor progression in cervical cancer. Sci. Rep. 14, 27063. https:\/\/doi.org\/10.1038\/s41598-024-75770-x (2024).","journal-title":"Sci. Rep."},{"key":"16026_CR52","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s12032-013-0826-y","volume":"31","author":"W Yang","year":"2014","unstructured":"Yang, W., He, M., Zhao, J. & Wang, Z. Association of ITGA3 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma. Med. Oncol. 31, 826. https:\/\/doi.org\/10.1007\/s12032-013-0826-y (2014).","journal-title":"Med. Oncol."},{"key":"16026_CR53","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.21037\/tcr-24-834","volume":"13","author":"Y Tang","year":"2024","unstructured":"Tang, Y. et al. Bioinformatics analysis reveals vegfc\u2019s prognostic significance in head and neck squamous cell carcinoma and its association with immune cell infiltration. Transl Cancer Res. 13, 5953\u20135970. https:\/\/doi.org\/10.21037\/tcr-24-834 (2024).","journal-title":"Transl Cancer Res."},{"key":"16026_CR54","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7150\/jca.91627","volume":"15","author":"YB Pan","year":"2024","unstructured":"Pan, Y. B. et al. Anoikis-related signature identifies tumor microenvironment landscape and predicts prognosis and drug sensitivity in colorectal cancer. J. Cancer. 15, 841\u2013857. https:\/\/doi.org\/10.7150\/jca.91627 (2024).","journal-title":"J. Cancer"},{"key":"16026_CR55","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/cas.12220","volume":"104","author":"T Shirakihara","year":"2013","unstructured":"Shirakihara, T. et al. Identification of integrin alpha3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes. Cancer Sci. 104, 1189\u20131197. https:\/\/doi.org\/10.1111\/cas.12220 (2013).","journal-title":"Cancer Sci."},{"key":"16026_CR56","doi-asserted-by":"publisher","first-page":"11983","DOI":"10.1002\/cam4.5873","volume":"12","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. ITGA5 promotes tumor angiogenesis in cervical cancer. Cancer Med. 12, 11983\u201311999. https:\/\/doi.org\/10.1002\/cam4.5873 (2023).","journal-title":"Cancer Med."},{"key":"16026_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12943-024-01944-w","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang, C. et al. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK\/PI3K\/AKT activation in a CeRNA manner. Mol. Cancer. 23, 33. https:\/\/doi.org\/10.1186\/s12943-024-01944-w (2024).","journal-title":"Mol. Cancer"},{"key":"16026_CR58","doi-asserted-by":"publisher","unstructured":"Wang, J. F. et al. ITGA5 Promotes tumor progression through the activation of the FAK\/AKT signaling pathway in human gastric cancer. Oxid Med Cell Longev 8611306 (2022). (2022). https:\/\/doi.org\/10.1155\/2022\/8611306","DOI":"10.1155\/2022\/8611306"},{"key":"16026_CR59","doi-asserted-by":"publisher","unstructured":"Ralli, M. et al. Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions. J Immunol Res 9235638 (2020). (2020). https:\/\/doi.org\/10.1155\/2020\/9235638","DOI":"10.1155\/2020\/9235638"},{"key":"16026_CR60","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1200\/JCO.21.01497","volume":"40","author":"M Reck","year":"2022","unstructured":"Reck, M., Remon, J. & Hellmann, M. D. First-line immunotherapy for non-small-cell lung cancer. J. Clin. Oncol. 40, 586\u2013597. https:\/\/doi.org\/10.1200\/JCO.21.01497 (2022).","journal-title":"J. Clin. Oncol."},{"key":"16026_CR61","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrurol.2018.43","volume":"15","author":"C Thoma","year":"2018","unstructured":"Thoma, C. Kidney cancer: combining targeted and immunotherapy. Nat. Rev. Urol. 15, 263. https:\/\/doi.org\/10.1038\/nrurol.2018.43 (2018).","journal-title":"Nat. Rev. Urol."},{"key":"16026_CR62","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMe2402364","volume":"390","author":"MH Voss","year":"2024","unstructured":"Voss, M. H. & Motzer, R. J. Adjuvant immunotherapy for kidney cancer - a new strategy with new challenges. N Engl. J. Med. 390, 1432\u20131433. https:\/\/doi.org\/10.1056\/NEJMe2402364 (2024).","journal-title":"N Engl. J. Med."},{"key":"16026_CR63","doi-asserted-by":"publisher","first-page":"101199","DOI":"10.1016\/j.xcrm.2023.101199","volume":"4","author":"D Sridaran","year":"2023","unstructured":"Sridaran, D. et al. Prostate cancer immunotherapy: improving clinical outcomes with a multi-pronged approach. Cell. Rep. Med. 4, 101199. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101199 (2023).","journal-title":"Cell. Rep. Med."},{"key":"16026_CR64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Liu, X., Jin, S., Chen, Y. & Guo, R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol. Cancer. 21, 47. https:\/\/doi.org\/10.1186\/s12943-022-01530-y (2022).","journal-title":"Mol. Cancer"},{"key":"16026_CR65","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","volume":"5","author":"H Zheng","year":"2024","unstructured":"Zheng, H. et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat. Cancer. 5, 572\u2013589. https:\/\/doi.org\/10.1038\/s43018-023-00715-8 (2024).","journal-title":"Nat. Cancer"},{"key":"16026_CR66","doi-asserted-by":"publisher","unstructured":"Liao, P. et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40, 365\u2013378 e366 (2022). https:\/\/doi.org\/10.1016\/j.ccell.2022.02.003","DOI":"10.1016\/j.ccell.2022.02.003"},{"key":"16026_CR67","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell. Metab. 33, 1001\u20131012. https:\/\/doi.org\/10.1016\/j.cmet.2021.02.015 (2021). e1005.","journal-title":"Cell. Metab."},{"key":"16026_CR68","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcmgh.2023.03.001","volume":"16","author":"JW Cheu","year":"2023","unstructured":"Cheu, J. W. et al. Ferroptosis suppressor protein 1 Inhibition promotes tumor ferroptosis and anti-tumor immune responses in liver cancer. Cell. Mol. Gastroenterol. Hepatol. 16, 133\u2013159. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.03.001 (2023).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"16026_CR69","doi-asserted-by":"publisher","first-page":"eadg3049","DOI":"10.1126\/scitranslmed.adg3049","volume":"15","author":"J Li","year":"2023","unstructured":"Li, J. et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci. Transl Med. 15, eadg3049. https:\/\/doi.org\/10.1126\/scitranslmed.adg3049 (2023).","journal-title":"Sci. Transl Med."},{"key":"16026_CR70","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","volume":"72","author":"C Conche","year":"2023","unstructured":"Conche, C. et al. Combining ferroptosis induction with MDSC Blockade renders primary tumours and metastases in liver sensitive to immune checkpoint Blockade. Gut 72, 1774\u20131782. https:\/\/doi.org\/10.1136\/gutjnl-2022-327909 (2023).","journal-title":"Gut"},{"key":"16026_CR71","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/s41419-018-1164-y","volume":"9","author":"Q Peng","year":"2018","unstructured":"Peng, Q. et al. EPH receptor A2 governs a feedback loop that activates Wnt\/beta-catenin signaling in gastric cancer. Cell. Death Dis. 9, 1146. https:\/\/doi.org\/10.1038\/s41419-018-1164-y (2018).","journal-title":"Cell. Death Dis."},{"key":"16026_CR72","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han, Y. et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 51, D1425\u2013D1431. https:\/\/doi.org\/10.1093\/nar\/gkac959 (2023).","journal-title":"Nucleic Acids Res."},{"key":"16026_CR73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12935-020-1113-6","volume":"20","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma. Cancer Cell. Int. 20, 27. https:\/\/doi.org\/10.1186\/s12935-020-1113-6 (2020).","journal-title":"Cancer Cell. Int."},{"key":"16026_CR74","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1 (2018).","journal-title":"Nat. Med."},{"key":"16026_CR75","doi-asserted-by":"publisher","unstructured":"Sturm, G. et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics 35, i436-i445 (2019). https:\/\/doi.org\/10.1093\/bioinformatics\/btz363","DOI":"10.1093\/bioinformatics\/btz363"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16026-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16026-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16026-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T04:51:22Z","timestamp":1755406282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16026-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16026"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16026-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,17]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30046"}}